Association of Community-Level Social Vulnerability With Clinical Trial Discussion and Participation Among Cancer Survivors.

These findings suggest interventions to identify socially vulnerable communities for expansion of clinical trial opportunities and infrastructure may be an impactful strategy toward improving diversity and representation in cancer clinical trials.